fluorodeoxyglucose f18 has been researched along with clodronic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khuri, F; Saba, N | 1 |
| Somay, E; Topkan, E; Yilmaz, B | 1 |
1 review(s) available for fluorodeoxyglucose f18 and clodronic acid
| Article | Year |
|---|---|
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clodronic Acid; Diphosphonates; Etidronic Acid; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Imidazoles; Lung Neoplasms; Pamidronate; Positron-Emission Tomography; Predictive Value of Tests; Therapeutic Equivalency; Zoledronic Acid | 2005 |
1 other study(ies) available for fluorodeoxyglucose f18 and clodronic acid
| Article | Year |
|---|---|
Comments on Dinnoo et al., 2021: ''18F-FDG PET/CT for early response assessment of jaw osteoradionecrosis after the PENTOCLO protocol: A promising imaging modality''.
Topics: Clodronic Acid; Fluorodeoxyglucose F18; Humans; Osteoradionecrosis; Positron Emission Tomography Computed Tomography | 2023 |